JPWO2021009684A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021009684A5
JPWO2021009684A5 JP2022502928A JP2022502928A JPWO2021009684A5 JP WO2021009684 A5 JPWO2021009684 A5 JP WO2021009684A5 JP 2022502928 A JP2022502928 A JP 2022502928A JP 2022502928 A JP2022502928 A JP 2022502928A JP WO2021009684 A5 JPWO2021009684 A5 JP WO2021009684A5
Authority
JP
Japan
Prior art keywords
amino acid
composition
seq
acid sequence
capsid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022502928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541520A (ja
JP7681277B2 (ja
JP2022541520A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/056635 external-priority patent/WO2021009684A1/en
Publication of JP2022541520A publication Critical patent/JP2022541520A/ja
Publication of JPWO2021009684A5 publication Critical patent/JPWO2021009684A5/ja
Publication of JP2022541520A5 publication Critical patent/JP2022541520A5/ja
Application granted granted Critical
Publication of JP7681277B2 publication Critical patent/JP7681277B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022502928A 2019-07-15 2020-07-15 関節炎疾患の治療のための修飾aavキャプシドタンパク質 Active JP7681277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2023505 2019-07-15
NL2023505 2019-07-15
PCT/IB2020/056635 WO2021009684A1 (en) 2019-07-15 2020-07-15 Modified aav capsid proteins for treatment of arthritic disease

Publications (4)

Publication Number Publication Date
JP2022541520A JP2022541520A (ja) 2022-09-26
JPWO2021009684A5 true JPWO2021009684A5 (https=) 2023-07-21
JP2022541520A5 JP2022541520A5 (https=) 2023-07-21
JP7681277B2 JP7681277B2 (ja) 2025-05-22

Family

ID=68425203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502928A Active JP7681277B2 (ja) 2019-07-15 2020-07-15 関節炎疾患の治療のための修飾aavキャプシドタンパク質

Country Status (23)

Country Link
US (1) US20220267797A1 (https=)
EP (1) EP3999119B1 (https=)
JP (1) JP7681277B2 (https=)
KR (1) KR20220081971A (https=)
CN (1) CN114502737B (https=)
AU (1) AU2020314883A1 (https=)
BR (1) BR112022000724A2 (https=)
CA (1) CA3146791A1 (https=)
DK (1) DK3999119T3 (https=)
ES (1) ES2998884T3 (https=)
FI (1) FI3999119T3 (https=)
HR (1) HRP20241647T1 (https=)
HU (1) HUE069369T2 (https=)
IL (1) IL289826A (https=)
LT (1) LT3999119T (https=)
MX (1) MX2022000551A (https=)
PH (1) PH12022550109A1 (https=)
PL (1) PL3999119T3 (https=)
PT (1) PT3999119T (https=)
RS (1) RS66255B1 (https=)
SI (1) SI3999119T1 (https=)
SM (1) SMT202400486T1 (https=)
WO (1) WO2021009684A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006056RA (en) * 2018-01-17 2020-07-29 Meiragtx Uk Ii Ltd A modified raav capsid protein for gene therapy
MX2024004217A (es) 2021-10-08 2024-06-26 Dyno Therapeutics Inc Variantes de cápside y métodos de uso de estas.
IL313832A (en) * 2021-12-28 2024-08-01 Chengdu Origen Biotechnology Co Ltd Modified AAV capsid protein and its use
TW202502803A (zh) 2023-03-10 2025-01-16 美商戴諾治療公司 衣殼多肽及其使用方法
CN121311235A (zh) 2023-04-13 2026-01-09 梅里特斯基因调控有限公司 炎症诱导型启动子
TW202525832A (zh) 2023-08-31 2025-07-01 美商戴諾治療公司 衣殼多肽及其使用方法(二)
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
WO2003042361A2 (en) 2001-11-09 2003-05-22 Government Of The United States Of America, Department Of Health And Human Services Production of adeno-associated virus in insect cells
WO2006110689A2 (en) * 2005-04-07 2006-10-19 The Trustees Of The University Of Pennsylvania Method of increasing the function of an aav vector
EP2311967B1 (en) 2005-10-20 2017-09-20 UniQure IP B.V. Improved AAV vectors produced in insect cells
KR101589259B1 (ko) 2006-06-21 2016-02-01 유니큐어 아이피 비.브이. 곤충세포 내 aav의 생산에 유용한 aav-rep78의 번역을 위한 변형된 개시 코돈을 갖는 벡터
ES2385679T3 (es) 2006-08-24 2012-07-30 Virovek, Inc. Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
SI3093345T1 (sl) 2007-07-26 2019-08-30 Uniqure Ip B.V. Bakulovirusni vektorji, ki vsebujejo ponavljajoča kodirna zaporedja z različnimi kodonskimi preferencami
EP3257937B1 (en) 2008-02-19 2022-08-03 uniQure IP B.V. Optimisation of expression of parvoviral rep and cap proteins in insect cells
WO2009154452A1 (en) 2008-06-17 2009-12-23 Amsterdam Molecular Therapeutics B.V. Parvoviral capsid with incorporated Gly-Ala repeat region
WO2011112089A2 (en) 2010-03-11 2011-09-15 Amsterdam Molecular Therapeutics (Amt) Ip B.V. Mutated rep encoding sequences for use in aav production
PT2744895E (pt) 2011-09-08 2016-02-08 Uniqure Ip Bv Remoção de vírus contaminantes de preparações de aav
WO2013174760A1 (en) * 2012-05-25 2013-11-28 Deutsches Krebsforschungszentrum Optimized aav-vectors for high transduction rates in dendritic cells
GB201403684D0 (en) * 2014-03-03 2014-04-16 King S College London Vector
IL248102B (en) * 2014-05-02 2022-07-01 Genzyme Corp aav vectors for gene therapy of the central nervous system and retina
CN107002096A (zh) 2014-10-06 2017-08-01 阿罗根有限公司 基于aav的基因疗法
FI3445773T3 (fi) * 2016-05-13 2023-03-30 4D Molecular Therapeutics Inc Adenoassosioituneen viruksen kapsidimuunnoksia ja niiden käyttömenetelmiä
CN109843306A (zh) 2016-08-19 2019-06-04 卡琳缪恩股份有限公司 使用自身互补型重组腺相关病毒治疗病症的方法和组合物
KR20250121159A (ko) 2016-12-07 2025-08-11 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 인터류킨-1 수용체 길항제(IL-1RA) cDNA
US20200370039A1 (en) * 2017-04-11 2020-11-26 Ruprecht-Karls-Universitat Heidelberg Adeno-associated virus library
SG11202006056RA (en) * 2018-01-17 2020-07-29 Meiragtx Uk Ii Ltd A modified raav capsid protein for gene therapy

Similar Documents

Publication Publication Date Title
EP0617126B1 (en) Polypeptide capable of inhibiting the binding between human IL-6 and its receptor
KR102923245B1 (ko) Tslp-관련 질환에 대한 치료제의 개발 및 적용
HRP20241647T1 (hr) Modificirani proteini aav kapsida za liječenje artritične bolesti
JP2804237B2 (ja) 組換えリンホトキシンをコードするdna
AU679909B2 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
HRP20231126T1 (hr) Modificirani protein kapsida raav za gensku terapiju
US8394771B1 (en) Multimeric proteins and methods of making and using same
CN115043938B (zh) SARS-CoV-2及其突变株的抗体及应用
JP2021510528A5 (https=)
JP2004516013A5 (https=)
CN107787329B (zh) 以高亲和力、亲和性及特异性结合转化生长因子-β1的经修饰的IgG抗体
WO1984002129A1 (fr) Proteine de l'interferon immun humain et son procede de preparation
US9731007B2 (en) Tumour necrosis factor receptor fusion proteins and methods of using the same
TW202116803A (zh) Gipr抗體及其與glp-1的融合蛋白質,以及其藥物組合物和應用
EA002543B1 (ru) Антитела против рецептора интерферона-альфа/бета
WO2021008519A1 (zh) ETA抗体与TGF-βTrap的融合蛋白质,以及其药物组合物和应用
JPWO2021009684A5 (https=)
CN117659189A (zh) Gipr抗体及其与fgf21的融合蛋白,以及其药物组合物和应用
CN117126279A (zh) Gipr抗体及其与glp-1的融合蛋白质,以及其药物组合物和应用
WO2024125667A1 (zh) 一种针对SARS-CoV或SARS-CoV-2的单克隆抗体、其制备方法及应用
JP2003524389A5 (https=)
JP7300008B2 (ja) 低免疫原性かつ低ADCC/CDC機能の抗TNF-αヒト化モノクローナル抗体TCX060およびその使用
WO2020248967A1 (zh) Eta抗体与bnp的融合蛋白质,以及其药物组合物和应用
WO2025146121A1 (zh) Ghr激动型抗体及其应用
AU2012207040B2 (en) Multimeric proteins and methods of making and using same